Follow
James Galvin
James Galvin
Professor of Neurology, University of Miami Miller School of Medicine
Verified email at miami.edu
Title
Cited by
Cited by
Year
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ...
Neurology 65 (12), 1863-1872, 2005
57812005
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ...
Neurology 89 (1), 88-100, 2017
34722017
The AD8: a brief informant interview to detect dementia
JE Galvin, CM Roe, KK Powlishta, MA Coats, SJ Muich, E Grant, JP Miller, ...
Neurology 65 (4), 559-564, 2005
10912005
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
10112016
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
JF Quinn, R Raman, RG Thomas, K Yurko-Mauro, EB Nelson, C Van Dyck, ...
Jama 304 (17), 1903-1911, 2010
8962010
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein
P Tu, JE Galvin, M Baba, B Giasson, T Tomita, S Leight, S Nakajo, ...
Annals of neurology 44 (3), 415-422, 1998
7481998
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
HI Hurtig, JQ Trojanowski, J Galvin, D Ewbank, ML Schmidt, VMY Lee, ...
Neurology 54 (10), 1916-1921, 2000
7272000
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers
CF Lippa, JE Duda, M Grossman, HI Hurtig, D Aarsland, BF Boeve, ...
Neurology 68 (11), 812-819, 2007
6872007
Synucleinopathies: clinical and pathological implications
JE Galvin, VMY Lee, JQ Trojanowski
Archives of neurology 58 (2), 186-190, 2001
5752001
Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein
JE Galvin, K Uryu, VMY Lee, JQ Trojanowski
Proceedings of the National Academy of Sciences 96 (23), 13450-13455, 1999
5201999
Validity and reliability of the AD8 informant interview in dementia
JE Galvin, CM Roe, C Xiong, JC Morris
Neurology 67 (11), 1942-1948, 2006
4792006
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
IG McKeith, TJ Ferman, AJ Thomas, F Blanc, BF Boeve, H Fujishiro, ...
Neurology 94 (17), 743-755, 2020
4632020
Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease
AS Fleisher, R Raman, ER Siemers, L Becerra, CM Clark, RA Dean, ...
Archives of neurology 65 (8), 1031-1038, 2008
4342008
Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease
ER Siemers, JF Quinn, J Kaye, MR Farlow, A Porsteinsson, P Tariot, ...
Neurology 66 (4), 602-604, 2006
4222006
Distinguishing Alzheimer’s disease from other major forms of dementia
S Karantzoulis, JE Galvin
Expert review of neurotherapeutics 11 (11), 1579-1591, 2011
4042011
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
M Sano, KL Bell, D Galasko, JE Galvin, RG Thomas, CH Van Dyck, ...
Neurology 77 (6), 556-563, 2011
3672011
Longitudinal study of the transition from healthy aging to Alzheimer disease
DK Johnson, M Storandt, JC Morris, JE Galvin
Archives of neurology 66 (10), 1254-1259, 2009
3642009
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
2952015
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
MM Williams, C Xiong, JC Morris, JE Galvin
Neurology 67 (11), 1935-1941, 2006
2952006
Clinical phenotype of Parkinson disease dementia
JE Galvin, J Pollack, JC Morris
Neurology 67 (9), 1605-1611, 2006
2922006
The system can't perform the operation now. Try again later.
Articles 1–20